MDLN
Medline Inc. NASDAQ$44.19
After hrs
$45.25
-0.15%
Mkt Cap $35.9B
52w Low $34.89
58.2% of range
52w High $50.88
50d MA $44.82
200d MA $44.30
P/E (TTM)
31.3x
EV/EBITDA
15.3x
P/B
1.9x
Debt/Equity
1.2x
ROE
-0.1%
P/FCF
19.6x
RSI (14)
—
ATR (14)
—
Beta
1.98
50d MA
$44.82
200d MA
$44.30
Avg Volume
5.8M
About
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front l…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | 0.24 | 0.22 | -7.6% | 48.18 | +2.5% | +1.5% | -1.4% | -4.8% | -7.9% | -11.0% | — |
| Nov 4, 2025 | AMC | — | 0.31 | — | — | — | — | — | — | — | — | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 | JP Morgan | Maintains | Overweight → Overweight | — | $43.41 | $43.53 | +0.3% | -1.2% | -2.3% | -5.4% | -4.5% | -3.8% |
| Mar 9 | BTIG | Maintains | Buy → Buy | — | $43.83 | $43.10 | -1.7% | -1.0% | -2.2% | -3.3% | -6.3% | -5.4% |
| Mar 9 | Tigress Financial | Maintains | Buy → Buy | — | $43.83 | $43.10 | -1.7% | -1.0% | -2.2% | -3.3% | -6.3% | -5.4% |
| Mar 2 | Morgan Stanley | Maintains | Overweight → Overweight | — | $47.51 | $47.14 | -0.8% | -3.5% | -6.6% | -9.7% | -7.3% | -7.7% |
| Feb 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $48.89 | $49.09 | +0.4% | -2.8% | -6.2% | -9.2% | -12.3% | -9.9% |
| Feb 26 | BMO Capital | Maintains | Outperform → Outperform | — | $48.18 | $49.38 | +2.5% | +1.5% | -1.4% | -4.8% | -7.9% | -11.0% |
| Feb 26 | Citigroup | Maintains | Buy → Buy | — | $48.18 | $49.38 | +2.5% | +1.5% | -1.4% | -4.8% | -7.9% | -11.0% |
| Feb 26 | Evercore ISI | Maintains | Outperform → Outperform | — | $48.18 | $49.38 | +2.5% | +1.5% | -1.4% | -4.8% | -7.9% | -11.0% |
| Feb 26 | RBC Capital | Maintains | Outperform → Outperform | — | $48.18 | $49.38 | +2.5% | +1.5% | -1.4% | -4.8% | -7.9% | -11.0% |
| Feb 26 | UBS | Maintains | Buy → Buy | — | $48.18 | $49.38 | +2.5% | +1.5% | -1.4% | -4.8% | -7.9% | -11.0% |
Recent Filings
Data updated apr 26, 2026 11:41am
· Source: massive.com